来氟米特治疗激素无效的过敏性紫癜肾炎临床观察 |
| |
引用本文: | 何萍,王维平,熊长青,朱鹏. 来氟米特治疗激素无效的过敏性紫癜肾炎临床观察[J]. 航空航天医学杂志, 2014, 25(1): 23-25 |
| |
作者姓名: | 何萍 王维平 熊长青 朱鹏 |
| |
作者单位: | 何萍(江苏省扬州市江都人民医院肾内科,江苏扬州,225200);王维平(江苏省扬州市江都人民医院肾内科,江苏扬州,225200);熊长青(江苏省扬州市江都人民医院肾内科,江苏扬州,225200);朱鹏(江苏省扬州市江都人民医院肾内科,江苏扬州,225200); |
| |
摘 要: | 目的探讨来氟米特治疗过敏性紫癜肾炎的治疗效果。方法将激素治疗无效的过敏性紫癜肾炎随机分为治疗组和对照组,治疗组予以来氟米特加泼尼松口服,对照组用强的松加雷公藤治疗,总疗程6个月。观察治疗前后24h尿蛋白定量、尿红细胞计数及血浆白蛋白,并观察患者的不良反应。结果治疗组的总有效率为90.9%,对照组总有效率为83.3%,两组之间比较无统计学意义(P〉0.05)。结论来氟米特联合泼尼松治疗激素无效的过敏性紫癜肾炎是安全和有效的。
|
关 键 词: | 来氟米特 过敏性紫癜肾炎 雷公藤 |
The Clinical Analysis of Leflunomide on Hormone Invalid Henoch- schonlein Purpura Nephritis |
| |
Affiliation: | HE Ping, WANG Weiping, XIONG Changqing, et al. ( Department of Nephrology, Jiangsu People's Hospital of Yangzhou, Yangzhou 225200, China) |
| |
Abstract: | Objective To investigate the clinical effectiveness and safe of leflunomide in the treatment of henoch - schonlein purpura nephritis. Methods 40 patients with hormone invalid henoch - schonlein purpura nephritis were divided into the control group (n = 18 ) and the treatment group (n = 22) randomly. The control group received tripterygium wilfordii and hormone, while the treatment group received leflunomide and hormone. To compare the clinical effectiveness and indexes. Results After treatment, Levels of 24h urinary protein and urinary RBC count were significantly declined (P 〈0.05 ) . After 6 months treatment, the total remission rate for the treatment group (90. 9% ) were higher than that for control group (83.3%) (P 〉0. 05). The adverse effect rate for treatment group ( 18.2% ) was lower than that for control group ( 50% ) ( P 〈 0. 05 ). Conclusions Leflunomide is safe and effective medicine in treating henoeh -sehonlein purpura nephritis. |
| |
Keywords: | leflunomide henoch - schonlein purpura nephritis tripterygium wilfordii |
本文献已被 维普 等数据库收录! |
|